Market News
4 min read | Updated on March 28, 2025, 03:33 IST
SUMMARY
Shri Ahimsa Naturals IPO allotment: The investors can check the allotment status on the NSE and the website of the issue registrar, Cameo Corporate Services Ltd.
Shri Ahimsa Naturals is a manufacturer of caffeine anhydrous natural, green coffee bean extracts and crude caffeine. | Image: Pixabay
Shri Ahimsa Naturals IPO allotment: Natural caffeine and green coffee extracts manufacturer Shri Ahimsa Naturals Ltd is likely to announce the IPO share allotment status on Friday, March 28, following the overwhelming subscription of its initial public offering.
The company launched the ₹73.81-crore IPO on March 25. The NSE SME issue garnered a strong response from investors on the first day, and it was fully subscribed.
On the last day of bidding on March 27, the IPO was overall subscribed 62.78 times. The investors applied for nearly 25.97 crore shares against 41.36 lakh shares on offer.
The non-institutional investors (NIIs) placed bids for 16.2 crore shares compared to 8.84 lakh shares on offer, leading to a subscription of 183.17 times in the category. The retail portion of the IPO was booked 35 times, with bids for more than 7.28 crore shares against 20.82 lakh shares on offer. The Qualified Institutional Buyers (QIBs) applied for more than 2.48 crore shares compared to 11.7 lakh shares set aside for them. The QIBs segment was booked 21.23 times.
The IPO investors can check the allotment status on the NSE and the website of the issue registrar, Cameo Corporate Services Ltd.
Shri Ahimsa Naturals is a manufacturer of Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE) and Crude Caffeine. It also trades in other herbal extracts. Its products are used in the food and beverage, nutraceuticals, cosmetics and pharmaceutical industries. The company processes crude caffeine procured from multiple decaffeination plants situated in Vietnam, Mexico and other countries.
The company has proposed to use the IPO proceeds for investment in its fully-owned subsidiary, Shri Ahimsa Healthcare Pvt Ltd (SAHPL), to set up a manufacturing facility in Jaipur, Rajasthan.
The company proposes to invest ₹35 crore in the new plant. The subsidiary has been formed for manufacturing and dealing in crude or natural caffeine and its other preparations.
Shri Ahimsa Naturals posted a profit after tax (PAT) of ₹ 9.74 crore for the April-September period of the financial year 2024-25. The company’s revenue from operations was at ₹40.71 crore in the first six months of the current fiscal.
The company reported a net profit of ₹18.66 crore in FY 2023-24 against ₹38.2 crore in FY 2022-23. Its revenue from operations in FY24 stood at ₹78.08 crore compared to ₹104.12 crore in FY23.
KPI | Value |
---|---|
Debt to equity ratio | 0.02 |
Return on Capital Employed | 12.59% |
Return on Equity | 9.78% |
P/E Ratio | 12.19 |
Net profit ratio | 23.93% |
About The Author
Next Story